readthroughSign in
CompanyALVOALVOWNasdaqLuxembourg, N4

Alvotech

Alvotech develops biosimilars targeting autoimmune disorders, eye disorders, and cancer.

SCHEDULE 13GNov 16Latest SEC filing
Oct 27Latest story